CloseDB Find Your Competitors

ACRES Global, Cambridge MA | Nearby Businesses


ACRES Global Reviews

1 Broadway, Fl 14th
Cambridge, MA 02142

+1 844 60-ACRES (22737)

The Alliance for Clinical Research Excellence and Safety (ACRES), a non-profit multi-sector alliance working in the public interest, brings together diverse stakeholders from across the clinical research enterprise and harnesses their expertise and investments to collaboratively build an open, integrated global system, based in principles of Accountable Research™. This system, employing integrated information technologies and interoperable standards, policies and practices across the global drug development enterprise, will enhance safety, quality and efficiency worldwide and industry-wide to benefit all stakeholders, especially patients.

Biotechnology Near ACRES Global

Novartis
Distance: 0.7 mi Competitive Analysis
250 Massachusetts Ave
Cambridge, MA 02139

(617) 871-8000

MIT Koch Institute for Integrative Cancer Research
Distance: 0.3 mi Competitive Analysis
500 Main St
Cambridge, MA 02139

(617) 253-6403

The Koch Institute grows out of and transcends the MIT Center for Cancer Research (CCR), which was founded in 1974 by Nobel Laureate and MIT Professor Salvador Luria. It is one of eight National Cancer Institute-designated basic (non-clinical) research centers in the U.S. Our mission is to apply the tools of science and technology to understand how cancer is caused, progresses and responds to treatment. We bring together scientists and engineers to discover how the disease behaves at a molecular level and to work on solving real cancer-related problems. The Koch Institute is both a physical entity and an organizing body for MIT's cancer research community at large (over 600 researchers across the Institute). It grows out of MIT's proven strengths in molecular biology, genetics, cell biology and immunology and stimulates extensive collaboration. The Koch Institute and its extramural partners comprise nearly 50 member laboratories from 7 departments.

Novartis Institute For Biomedical Research
Distance: 0.7 mi Competitive Analysis
250 Massachusetts Ave
Cambridge, MA 02139

(617) 871-8000

ALS TDI
Distance: 0.4 mi Competitive Analysis
300 Technology Sq Ste 4
Cambridge, MA 02139

(617) 441-7200

Since 1999, the ALS Therapy Development Institute has been dedicated to research. Developed by a family member whose brother had ALS, the emphasis has been to work closely with patients and their families to raise valuable funds to help slow down and eventually cure ALS.

Biogen
Distance: 0.3 mi Competitive Analysis
250 Binney St
Cambridge, MA 02142

(617) 679-2000

Biogen, Inc. (previously known as Biogen Idec) is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases to patients worldwide.HistoryBiogen was founded in 1978 in Geneva by several prominent biologists, including Kenneth Murray of the University of Edinburgh, Phillip Allen Sharp of the Massachusetts Institute of Technology, Walter Gilbert of Harvard (who served as CEO during the start-up phase), Heinz Schaller, University of Heidelberg and Charles Weissmann, University of Zurich (who contributed the first product interferon alpha). Gilbert and Sharp were subsequently honored with Nobel Prizes: Gilbert was recognized in 1980 with the Nobel Prize in Chemistry for his work in understanding DNA sequencing, while Sharp received the Nobel Prize in Physiology or Medicine in 1993 for his discovery of split genes.

Biogen
Distance: 0.2 mi Competitive Analysis
12 Cambridge Ctr
Cambridge, MA 02142-1481

(617) 679-2000

BBCR Consulting
Distance: 0.0 mi Competitive Analysis
1 Broadway, Fl 14th
Cambridge, MA 02142

(617) 401-2327

LabCentral
Distance: 0.6 mi Competitive Analysis
700 Main St
Cambridge, MA 02139

(617) 863-3650

WHAT IS LABCENTRAL? A 28,000 square-foot facility in the heart of the Kendall Square, Cambridge, biotech innovation hub, LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups. It offers fully permitted laboratory and office space for as many as 25 startups comprising approximately 100 scientists and entrepreneurs. LabCentral provides first-class facility and administrative support, skilled laboratory personnel, a domain-relevant expert speaker series ‒ as well as the other critical services and support that early-stage companies need to begin laboratory operations on day one. A private, nonprofit institution, LabCentral was funded in part by a $5 million grant from the Massachusetts Life Sciences Center, with support from its real-estate partner, MIT. Founding sponsors include Triumvirate Environmental and Johnson & Johnson Innovation. The first startups joined us in early November, with lab operations launching officially November 15, 2013. A Better Way for Life-Sciences Startups There has never been a shortage of groundbreaking science in Massachusetts, nor of talented people with entrepreneurial spirit and vision. What was lacking ‒ affordable, move-in-ready laboratory facilities suitable for early-stage research. LabCentral fills this gap. To paraphrase Doug Crawford, the executive director of LabCentral affiliate QB3/UCSF: Once biotech entrepreneurs are convinced that they should try to bring their work to market, either with or without bridging-the-gap funding, they are often astounded by the next mental adjustment: the amount of effort required to turn their attractive innovation into a useful product. Besides securing intellectual property and developing a business plan, the budding entrepreneur must find a location for the new company – ideally with low rent, important equipment provided, access to supporting services and other needed resources. [K. D. Harrison, N. S. Kadaba, R. B. Kelly, D. Crawford, Building a life sciences innovation ecosystem. Sci. Transl. Med. 4, 157fs37 (2012).] Successful co-working facilities have been built for aspiring IT companies in many centers of innovation, but there has been a paucity of laboratory spaces for biotech. Laboratory infrastructure is costly, and the initial investment is much larger than just a desk and a good broadband connection. Lease, fit-out, and permitting of lab space consumes precious resources ‒ both human and capital ‒ that could be better spend fine-tuning technology to prepare for clinical trials or commercialization. LabCentral solves this problem by adopting very conscious design choices to optimize use of available space, and to facilitate shared use of resources, equipment, and infrastructure. We combine this with a goal-oriented understanding of “concierge” services that remove many operational burdens from startup companies.

Bluebird Bio
Distance: 0.4 mi Competitive Analysis
150 2nd St
Cambridge, MA 02141

(339) 499-9300

Moderna Therapeutics
Distance: 0.4 mi Competitive Analysis
320 Bent St
Cambridge, MA 02141

(617) 714-6500

Moderna Therapeutics is pioneering messenger RNA therapeutics™, an entirely new in vivo drug modality that produces human proteins or antibodies inside patient cells, which are in turn active intracellularly or secreted. This breakthrough platform addresses currently undruggable targets, and offers a superior alternative to existing drug modalities for a wide range of disease conditions. Moderna has developed a broad intellectual property estate including more than 200 patent applications with more than 10,000 claims ranging from novel nucleotide chemistries to specific drug compositions. The company plans to develop and commercialize its innovative mRNA drugs—initially for rare diseases and oncology—while partnering drug candidates in other therapeutics areas in order to rapidly deliver this innovation to patients. Based in Cambridge, Massachusetts, Moderna is privately held and was founded in 2010 by Flagship VentureLabs in association with leading scientists from Boston Children’s Hospital and Massachusetts Institute of Technology.

MIT Department of Biological Engineering
Distance: 0.5 mi Competitive Analysis
16-429 Massachusetts Ave # 77
Cambridge, MA 02139

(617) 452-2464

The Department of Biological Engineering was founded in 1998 as a new MIT academic unit, with the mission of defining and establishing a new discipline fusing molecular life sciences with engineering. The goal of this biological engineering discipline is to advance fundamental understanding of how biological systems operate and to develop effective biology-based technologies for applications across a wide spectrum of societal needs including breakthroughs in diagnosis, treatment, and prevention of disease, in design of novel materials, devices, and processes, and in enhancing environmental health. Our departmental epigram is 'Creating Biological Technologies, from Discovery to Design', designating our intertwined emphases on advances in basic bioscience and in applied biotechnology. The innovative educational programs created by BE reflect this emphasis on integrating molecular and cellular biosciences with a quantitative, systems-oriented engineering analysis and synthesis approach, offering opportunities at the undergraduate level for the SB in Biological Engineering and at the graduate level for the PhD in either Applied Biosciences or Bioengineering. BE also partners with the departments of Biology and Electrical Engineering & Computer Science to jointly offer a PhD in Computational & Systems Biology, and with the departments of Biology and Civil & Environmental Engineering to jointly offer a PhD in Microbiology. Research opportunities for BE undergraduate students, graduate students, and postdoctoral associates abound across an exciting landscape of interdisciplinary laboratories, centers, and initiatives, including the Center for Biomedical Engineering, the Center for Environmental Health Sciences, the Center for Emergent Behavior of Integrative Cellular Systems, the Center for Gynepathology Research, the Synthetic Biology Center, and the Division of Comparative Medicine. Graduate students in the BE PhD programs can participate in the NIGMS Biotechnology Training Program, the NIEHS Toxicology Training Program, and the NIBIB Biomechanics Training Program. More than one-third of the MIT BE faculty hold membership in one or more of the major US academies, including 6 in the National Academy of Engineering, 5 in the National Academy of Science, 7 in the Institute of Medicine, and 6 in the American Academy of Arts & Sciences. BE is one of four bioengineering programs (along with UCSD, Berkeley/UCSF, and Caltech) assigned #1 rankings in the current National Research Council report, and ranks #1 among bioengineering departments in citations per publication in a recent Academic Analytics study. Numerous biotechnology companies have been generated by BE faculty and students, in the Cambridge/Boston area and further nationwide.

Mass Innovation Labs, LLC
Distance: 0.1 mi Competitive Analysis
675 W Kendall St
Cambridge, MA 02142

(888) 315-9598

We realized that small team research needs more than just space, but a platform to accelerate performance. Success requires flexible facilities, dynamic operations, and industry leading expertise on hand. We built this platform at the intersection of the world’s leading life science companies, VCs and academic institutions in the heart of Kendall Square. The whole is much larger than the sum of our partnerships and resources.

NeoScientific
Distance: 0.2 mi Competitive Analysis
245 1st St
Cambridge, MA 02141

(617) 679-9800

NeoBioLab is headquartered in the center of a biopharmaceutical zone located in Cambridge, Massachusetts. We are a dedicated biology service provider and partner, providing innovative solutions to molecular and cellular biology, in vivo experiments and drug screening services. NeoBioLab routinely works with pharmaceutical and biotechnological companies and academic institutions of all sizes, advancing their research efficiency and core competitiveness and ultimately improving their research productivity. NeoBioLab guarantees the quality of its products and services through multiple layers of quality control management. In addition, we seek strategic collaborators and integrate various resources so that we can maximize our talents in the discovery and development of medicines and therapies. NeoBioLab’s mission is to provide innovative solutions and accelerate the healthcare R&D.

Addgene
Distance: 1.0 mi Competitive Analysis
75 Sidney St
Cambridge, MA 02139-1666

(617) 225-9000

Lab central, Cambridge
Distance: 0.6 mi Competitive Analysis
700 Main St
Cambridge, MA 02139-3543

1617 863 3650

Aegerion Pharmaceuticals
Distance: 0.1 mi Competitive Analysis
101 Main Street
Cambridge, MA 02142

(617) 500-7867

Seven Bridges Genomics
Distance: 0.2 mi Competitive Analysis
1 Main St. Suite 500
Cambridge, MA 02142

(617) 294-6582

Discover and interpret variants with flexible, open-source pipelines and our scalable computation engine. Collaborate across your research network, privately share results, and draw from existing datasets.

Constellation Pharmaceuticals
Distance: 0.2 mi Competitive Analysis
215 1st St
Cambridge, MA 02142

(617) 714-0555

Developing novel medicines through scientific innovation to better patients' lives.

XLHED Network
Distance: 0.5 mi Competitive Analysis
55 Cambridge Pkwy, Ste 102W
Cambridge, MA 02142

(617) 758-4300

Edimer Pharmaceuticals is dedicated to developing EDI200 as a treatment for X-linked Hypohidrodic Ectodermal Dysplasia (XLHED). XLHED is a rare orphan disease that causes a range of symptoms including lack of sweat glands, poor temperature control, respiratory problems, and hair and tooth malformations. Edimer is led by a team of seasoned biotechnology industry veterans with deep experience in drug development complemented by a strong network of world-class clinical and scientific advisors. The company is based in Cambridge, Massachusetts.

XRpro Sciences, Inc.
Distance: 0.5 mi Competitive Analysis
1 Kendall Sq
Cambridge, MA 02139

(617) 631-8825

XRpro Sciences, Inc. provides high-value services -- from assay development and high throughput screening through data analysis -- for ion channels and transporters using its proprietary, lablel-free XRpro® technology. XRpro® technology, based on X-ray fluorescence, is a novel method that enables high throughput assessment of ion channels and transporters including challenging assays that are difficult or impossible to conduct using other technologies. XRpro Sciences is dedicated to solving the challenges scientists face by bringing the value of XRpro® technology to their ion channel and transporter research and drug development activities. Our services combine the expertise and capabilities of our scientific team with a collaborative environment to provide new scientific insights and promote development of quality drug candidates. Advantages of XRpro® Technology: - Label-free - No dyes or radiolabels - Works in complex matrices - Serum, high DMSO, opaque solutions - Broad range of targets - ion channels, transporters, and other challenging targets - Straightforward assay implementation - uses standard cell biology, microplates, automation, and assay procedures

Non-Profit Organization Near ACRES Global

NEHI
Distance: 0.0 mi Competitive Analysis
1 Broadway, Fl 15th
Cambridge, MA 02142

(617) 225-0857

NEHI (Network for Excellence in Health Innovation) is a health policy institute focused on enabling innovation that will improve health care quality and lower health care costs. Working in partnership with members from across the health care system, NEHI brings an objective, collaborative and fresh voice to health policy. We combine the collective vision of our diverse membership and our independent, evidence-based research to move ideas into action.

The Veritas Forum - www.veritas.org
Distance: 0.0 mi Competitive Analysis
1 Broadway, Fl 14th
Cambridge, MA 02142

(617) 491-2055

The Veritas Forum invites students and faculty to ask life's hardest questions. With a commitment to courageous discourse we put the historic Christian faith in dialogue with other beliefs and invite participants from all backgrounds to pursue Truth together. Founded at Harvard in 1992, The Veritas Forum now partners on dialogues at over 130 leading universities in North America and Europe. Past presenters include Francis Collins, Tim Keller, N. T. Wright, Marilynne Robinson, Peter Singer, Nicholas Kristof, Cornel West, Condoleezza Rice, Steven Pinker, and Jean Bethke Elshtain.

EYE Can Do it
Distance: 0.0 mi Competitive Analysis
1 Broadway, Fl 14th
Cambridge, MA 02142

(617) 401-2779

EyeCanDoIt.org is a patient-friendly web resource about vision awareness for patients with diabetes.

SciBr Foundation
Distance: 0.0 mi Competitive Analysis
1 Broadway, Fl 14th
Cambridge, MA 02142

Brazilian Connection to Knowledge, Innovation and Creativity Our mission is to connect Brazilian scientists, artists and entrepreneurs working abroad and to mobilize their talents to create a more prosperous, fair and sustainable Brazil.

Venture Café Foundation
Distance: 0.0 mi Competitive Analysis
1 Broadway, 5th Floor
Cambridge, MA 02142

(617) 758-4128

The mission of the Venture Café Foundation consists of three pillars: - Building and connecting communities of innovation locally, nationally, and internationally. - Expanding the definition of innovation and entrepreneurship. They are not just about making apps . - Building a more inclusive innovation economy. We want to make sure that questions about inequality and inclusion are part of the innovation and entrepreneurship conversation –not an afterthought.

Eat To Defeat Cancer
Distance: 0.0 mi Competitive Analysis
1 Broadway
Cambridge, MA 02142

(617) 401-2771

More than 1-in-3 people will have cancer in their lifetime. Even more eye opening is that tiny, microscopic cancers are developing in our bodies all the time, even before we are old. It is whether blood vessels near these dormant tumors are held in check or instead grow that determines if the cancer will expand and spread. Angiogenesis is the name of the natural process that blood vessels grow in the body. How important are these vessels? The healthy body maintains its blood vessels in a continuous state of balance. Cancer develops into a disease when abnormal cells overcome this balanced state and new blood vessels grow to feed cancers. But these blood vessels are also cancer's Achilles Heel. Cutting off a tumor’s blood supply starves it of oxygen and nutrients. Forty years of research has now resulted in modern drugs that effectively combat cancer through anti-angiogenesis. These drugs effectively starve growing cancers in a way totally different from toxic chemotherapy, radiation, or surgery. Novel drugs based on this unique approach have been successfully tested in thousands of patients, been approved by the FDA and other drug agencies throughout the world and have helped increase the survival and quality of life of people living with cancer. The anti-angiogenesis approach has been proven to be an effective in fighting cancers. Targeting angiogenesis also provides an opportunity to prevent cancer. Certain foods contain natural molecules that can suppress abnormally growing blood vessels. What separates Eat to Beat is its focus on what you should add to your diet, rather than what to eliminate.

Learning Insync
Distance: 0.0 mi Competitive Analysis
1 Broadway
Cambridge, MA 02142

(607) 768-1386

Technology Exchange Lab, Inc.
Distance: 0.0 mi Competitive Analysis
1 Broadway
Cambridge, MA 02142

TEL is dedicated to bringing communities out of poverty by driving the adoption of innovative, cost-effective and sustainable solutions that improve the lives at the bottom of the pyramid. We host a crowdsourced database of over 600 innovations in order to connect practical solutions to the people who need them most. Through our Project Accelerator service, we help NGOs and communities leverage appropriate technology solutions to maximize the impact of last-mile development.

Digital Independence
Distance: 0.0 mi Competitive Analysis
1 Broadway
Cambridge, MA 02142

617-299-MYDI (6934)

SoL - Society for Organizational Learning
Distance: 0.0 mi Competitive Analysis
1 Broadway
Cambridge, MA 02142

(617) 300-9500

US Offshore Wind Collaborative
Distance: 0.0 mi Competitive Analysis
1 Broadway
Cambridge, MA 02142

The Collaborative’ s Board of Directors and Program Partners include national leaders in government, industry, academia, and environmental advocacy. Our work is non-partisan and framed by four organizing principles: • Over-dependence on fossil fuels has immediate, cumulative, and systemic impacts on human health, the environment, and national security. America must aggressively pursue cleaner, more sustainable and secure energy pathways now. • Offshore wind, an abundant renewable resource close to major load centers, is the best opportunity for coastal and Great Lakes regions to make a significant contribution to the nation’s energy portfolio. Taking on the short-term challenges associated with building this new clean energy industry will yield long-term energy, environmental and economic benefits. • Market-scale offshore wind development has transformative economic potential: industrial scale job creation, new manufacturing, advanced transmission, and revitalized maritime infrastructure. Realizing this potential requires a long-term, market-based, sustainable industrial development strategy. • Seizing the offshore wind opportunity calls for regional infrastructure and deployment approaches, supported by national clean energy policy and federal investment. Individual state action alone is not enough to build a cost-competitive domestic offshore wind industry.

The BioExec Institute
Distance: 0.0 mi Competitive Analysis
1 Broadway, Fl 14th
Cambridge, MA 02142

Open Learning Exchange - www.ole.org
Distance: 0.0 mi Competitive Analysis
Cambridge Innovation Center / 1 Broadway
Cambridge, MA 02142

(617) 401-2300

OLE realizes that there is no ‘one size fits all’ answer when it comes to improving education. We are therefore committed to implementing customized learning solutions — and to providing local educators with the essential training to foster successful employment of these processes. In order to do this, we maintain a ‘catalogue’ of robust learning solutions that can be adapted to fit a wide variety of educational needs and contexts.

Massachusetts Ovarian Cancer License Plate Initiative
Distance: 0.1 mi Competitive Analysis
P.O. Box 426111
Cambridge, MA 02142

(617) 413-7751

My mom, Margaret, was diagnosed in October, 2007 with Stage III Ovarian Cancer. Our family was devastated and had no idea about Ovarian Cancer. After learning more than we ever wanted to know, we realized my mom experienced all the symptoms – bloating, pelvic or abdominal pain, trouble eating or feeling full quickly, feeling the need to urinate urgently or often. After 11 months filled with doctors’ appointments, treatments, and side effects, my mom lost her battle on September 19, 2008. During the last three years of grieving, I had wanted to do something to honor my mother, but couldn’t decide what effort would be worthy of my mom’s name...until this fall. In September 2011, I launched a non-profit organization, Margaret’s Mission for Ovarian Cancer Awareness, to sponsor an initiative to obtain the first Ovarian Cancer Awareness specialty license plate in Massachusetts. In order for the Massachusetts Department of Motor Vehicles to begin manufacturing the Ovarian Cancer Awareness specialty license plate, we must obtain 750 pre-paid orders for the plate. Although the rate at which we are receiving applications is slow, we are dedicated to this effort and sure that we will reach this goal. The goal of this initiative is to raise awareness of Ovarian Cancer to educate women (and those who love them) about the symptoms and the importance of early detection, which can save lives. It is my hope that people will see this plate, Google it and learn all about this devastating disease to extend the lives of women, both young and old.

Friends of the Red Cross
Distance: 0.1 mi Competitive Analysis
139 Main St
Cambridge, MA 02142

(617) 274-5200

TiE-Boston
Distance: 0.1 mi Competitive Analysis
101 Main St, 14th Floor
Cambridge, MA 02142

(617) 225-0419

Women's Action for New Directions
Distance: 0.1 mi Competitive Analysis
101 Main Street
Cambridge, MA 02142

(617) 401-2877

MIT Clean Energy Prize
Distance: 0.1 mi Competitive Analysis
1 Amherst St
Cambridge, MA 02142

The Clean Energy Prize innovation and entrepreneurship competition awards over $400,000 in prizes to cutting-edge startups from universities across the US. We prepare tomorrow's clean energy leaders by advancing their relationships with academic, community, industry, and government players to help them meet the world’s pressing energy challenges. The CEP is generously sponsored by: Title Sponsor: NSTAR Gigawatt Sponsors: GE and GDF Suez Legal Sponsor: Morrison and Foerster Megawatt Sponsors: Factor(E) and the Massachusetts Clean Energy Center

MIT AgeLab
Distance: 0.1 mi Competitive Analysis
1 Amherst Street, Room E40-279 Muckley Building
Cambridge, MA 02142

(617) 324-9054

Based within MIT’s School of Engineering’s Engineering Systems Division, the AgeLab has assembled a multi-disciplinary team of researchers, business partners, universities, and the aging community to design, develop and deploy innovations that touch nearly all aspects of how we will live, work and play tomorrow.